Nervous System Neoplasm — Trials

Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 608 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06816927	Trial of Glioblastoma Immunotherapy Advancement With Nivolumab and Relatlimab(GIANT)	recruiting	Phase 2	92	Duke UniversityOTHER	2	Sep 17, 2026	clinicaltrials
NCT07537400	Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5	recruiting	Phase 2	10	Shaare Zedek Medical CenterOTHER